Brief: Helix Biopharma Corp announces licence for worldwide right to anti-CEACAM6 antibody from Government of Canada
27/02/2017 12:32
Feb 27 (Reuters) - Helix Biopharma Corp HBP.TO
* Helix Biopharma Corp. Announces licence for worldwide
right to anti-CEACAM6 antibody from the Government of Canada
Source text for Eikon: ID:nMKWqtYjHa
Further company coverage: HBP.TO
((bangalore.newsroom@thomsonreuters.com;))
Recent news on Helix Biopharma
See all newsBrief: Helix Biopharma Reports Q3 Loss Per Share C$0.02
Brief: Helix Biopharma Intends To File Interim Consolidated Financial Statements By July 30
Brief: Helix Biopharma To Divest Remaining Ownership Of Polish Subsidiary
Brief: Helix Biopharma Says Expects To File Interim Disclosure Documents By July 30, 2020
Brief: Helix Biopharma Says L-Dos47 Phase I Lung Cancer Trial Data To Be Released At Asco 2020